Despite a soft result in FY18, brokers remain confident in the longer-term ambitions of Collins Foods as the company’s expansion strategy is rolled out.
Strong demand for a number of metal detection and mining solution products has driven Codan to upgrade guidance, providing validation for a positive outlook from several brokers.
Ainsworth Game Technology has significantly downgraded guidance, made worse by the fact the revision includes a recent order from Churchill Downs.
WA craft brewer Gage Roads has won exclusive beer rights to the new Perth stadium. DJ Carmichael initiates coverage.
Soft retail conditions continue to cast a cloud over Australian Pharmaceutical Industries and brokers expect growth in FY18 will be a challenge.
As the migration of AMP accounts continue and the easy wins in cloud conversions pass, Class is likely to experience a more subdued period over coming months.
The baby goods retail industry has had its share of failures recently which puts Baby Bunting in the spotlight.
G Medical Innovations is a small medical device company with two key products it intends to distribute globally. TMT Analytics initiates coverage.
Brokers welcome the news that Medical Developments has received regulatory approval to market its pain-killing device Penthrox in Germany.
Regenerative medicine pioneer Orthocell closes in on market payday.